Amit Gupta, the Chief Executive Officer of Cardlytics, Inc. (NASDAQ:CDLX), recently executed a series of stock transactions involving the company's common stock. On January 23, 2025, Gupta acquired 43,750 shares of common stock through the conversion of restricted stock units (RSUs), a transaction that did not involve any monetary exchange. The transactions come at a time when Cardlytics, with a market capitalization of $197 million, has seen its stock surge 22.8% over the past week, according to InvestingPro data.
Subsequently, on January 24, 2025, Gupta sold 15,160 shares of Cardlytics common stock at an average price of $3.92 per share, generating a total of $59,427. The sale was carried out to satisfy tax withholding obligations related to the vesting of RSUs, as noted in the filing. Following these transactions, Gupta holds 215,494 shares of Cardlytics common stock directly. InvestingPro analysis reveals the stock has experienced significant volatility, with a 53.6% decline over the past six months. Subscribers can access 10 additional ProTips and comprehensive financial metrics in the Pro Research Report, offering deeper insights into Cardlytics' financial health and market position.
In other recent news, Cardlytics has released its third-quarter financial results for 2024, indicating a positive outlook for the final quarter of the year. The company is planning to enhance its offerings through new financial institution partnerships and operational and product initiatives. These plans aim to boost Cardlytics' financial performance and market position. However, the company acknowledges potential risk factors that could lead to different actual results from the discussed forecasts. Despite these uncertainties, Cardlytics remains optimistic about its future performance. These developments are part of Cardlytics' ongoing growth strategy, with detailed financial information available in the company's press release and SEC filings. As always, these forward-looking statements are subject to various risks that could affect actual results.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.